Myostatin is associated with the presence and development of acute-on-chronic liver failure
Myostatin is associated with the presence and development of acute-on-chronic liver failure - (2023)
Myostatin is associated with the presence and development of acute-on-chronic liver failure - (2023)
Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018) - (2023)
Epidemiology of liver transplantation and post-LT complications in Germany: nationwide study (2005-2018) - (2023)
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial - (2023)
The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure - (2024)
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial - (2023)
Operating under pressure: Is there a place for preoperative TIPS? - (2024)
Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery - (2024)
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers - (2024)
Review: Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases - (2024)